【國家藥監局批准培來加南噴霧劑上市】6月22日，據國家藥監局消息，近日，國家藥品監督管理局批准普萊醫藥（江蘇）股份有限公司申報的1類創新藥培來加南噴霧劑（商品名：普亦克）上市，該品種爲局部外用抗細菌藥物，適用於治療由表皮葡萄球菌、溶血葡萄球菌、鮑曼不動桿菌導致的Ⅰ度或淺Ⅱ度燒燙傷繼發創面感染。該藥品上市爲患者提供了新的治療選擇。

MOFCOM, the NDRC and the Ministry of Finance issued an action plan to leverage foreign investment to stabilise and upgrade growth in China, explicitly supporting foreign firms' participation in consumption-stimulus measures. The plan requires full inclusion of foreign companies in green-consumption programs and international consumption center city initiatives and prohibits excluding eligible products or services from consumption-support policies solely because they are foreign-branded or foreign-owned. It also orders improvements to the online business environment—setting up an enterprise-related online-infringement reporting linkage mechanism, streamlining handling procedures, publishing guidance for online reporting channels, and protecting foreign firms' legal rights online.

Kremlin says it is working urgently to minimize adverse impacts on fuel supplies to Crimea.